Accelevir conducts GLP-compliant biodistribution studies to quantify vector or therapeutic nucleic acid presence in multi-tissue panels for AAV, lentiviral, and mRNA therapy programs. Our workflows meet FDA/EMA biodistribution guidance.
Capabilities:
- High-sensitivity qPCR/dPCR detection of therapeutic vectors.
- Multi-species tissue panel processing (rodent, NHP, human).
- Automated nucleic acid extraction for consistent yield.
- Data packages aligned for regulatory biodistribution study submissions.
Applications:
- Regulatory biodistribution compliance for gene and cell therapy.
- Vector dissemination risk assessment.
- Dose route optimization in preclinical models.
- Persistence monitoring post-administration.